心脏衰竭与保存的喷射分数作为一个风险因素,在除后心房的复发
Xiao Ma1,2, Zhikang Huang1, Hengfeng Wu1
1The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Cardiovascular drugs and therapy
|February 4, 2026
概括
保存喷射分数 (HFpEF) 的心力衰竭显著增加了导管切除后心房动 (AF) 的复发. 患有持续性AF和HFpEF的患者面临最高风险,需要量身定制的治疗策略以改善结果.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏衰竭研究研究
背景情况:
- 心房动 (AF) 术后复发会影响患者的预后.
- 心力衰竭与保留喷射分数 (HFpEF) 对AF复发的影响尚未得到充分证实.
研究的目的:
- 调查HFpEF对AF复发率在导管切除后一年内的影响.
主要方法:
- 分析了一组455名接受AF切除术的患者队列,将HFpEF组的241名患者与非心力衰竭 (非HF) 组的213名患者进行比较.
- 使用卡普兰-梅尔分析,考克斯回归和倾向分数匹配 (PSM) 来评估复发率和确定预测因素.
主要成果:
- 在HFpEF组显示显著更高的一年AF复发率 (25.0%对比9.8%,P<0.001).
- HFpEF被确定为复发的独立风险因素 (HR=1.92),特别是在持续的AF病例中.
- 后PSM分析证实HFpEF是复发的唯一独立预测因子 (HR=2.42,P=0.017).
结论:
- HFpEF 是一个显著的独立风险因素,在去除后的一年AF复发.
- 患有持续性AF和HFpEF的患者出现复发风险最高.
- 个性化治疗策略对于优化这些患者的治疗结果至关重要.
相关概念视频
Factors Affecting the Risk of Infection
13.6K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.6K
Heart Failure II: Pathophysiology
952
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
952
Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Amyloid Fibrils
12.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348


